Article metrics

Download PDFPDF

Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study)

 

Online download statistics by month:

Online download statistics by month: May 2017 to September 2021

AbstractFullPdf
May 20175802247
Jun 201728248117
Jul 201714614683
Aug 2017747549
Sep 201722321934
Oct 201717116643
Nov 2017555541
Dec 2017535332
Jan 2018444418
Feb 2018272625
Mar 2018818250
Apr 201811911982
May 201812111795
Jun 2018928262
Jul 2018706456
Aug 2018424231
Sep 2018656530
Oct 2018919147
Nov 2018646419
Dec 2018353529
Jan 2019464622
Feb 2019515132
Mar 2019424245
Apr 2019484844
May 2019363536
Jun 2019444225
Jul 2019414023
Aug 2019191921
Sep 2019282732
Oct 2019414056
Nov 2019615649
Dec 2019545330
Jan 2020434118
Feb 2020312818
Mar 2020191817
Apr 202013137
May 2020424129
Jun 2020242418
Jul 2020545320
Aug 2020373614
Sep 202019199
Oct 2020555212
Nov 2020575717
Dec 202034345
Jan 2021353318
Feb 2021141425
Mar 2021383821
Apr 2021272513
May 202126247
Jun 202126268
Jul 202118189
Aug 202124246
Sep 2021232210
Total277637341906